Kirkland & Ellis Helps Linden Buy SeraCare For $82M
SeraCare Life Sciences Inc. will be purchased by Chicago-based private equity firm Linden Capital Partners in a deal worth $82 million, the Massachussetts-based medical diagnostics company said Monday....To view the full article, register now.
Already a subscriber? Click here to view full article